Last week I spent a few days at the A4M conference, one of the largest gatherings in the country focused on longevity and preventive medicine.
It brings together physicians and researchers working on what has become one of the most interesting questions in medicine. Not how long we live, but how well, and how many of those years we spend healthy. It is the question underneath everything we build our programs around.
I came home with more to think about than I expected. Not because the ideas were new, but because so many of them were converging on something our team has felt for a long time.
Do heart disease, dementia and cancer share a cause?
To a meaningful degree, yes. The three diseases of aging appear to share a common mechanism: a dysregulated immune system and chronic inflammation. Different organs, different timelines, one underlying story. For decades we have treated them as separate problems with separate specialists and separate medications.
On the drive home I kept thinking about something Eric Topol said in a recent Kara Swisher interview along exactly these lines.
His work, along with a growing body of research, suggests that what drives these conditions is more unified than we thought.
When the immune system loses its fine tuning, inflammation quietly accumulates in the arteries, in the brain, and in the tissues where cancer cells can take hold. What is encouraging is that this is modifiable. Significantly so.
What actually reduces chronic inflammation?
Largely the fundamentals. What we eat and how much. Sleep. Stress. Physical activity, and especially resistance training, which does more for healthy aging than almost anything else we can prescribe. None of that is new, which is precisely what makes the convergence interesting.
Alongside those fundamentals, medicine is producing real breakthroughs.
The GLP-1 medications are the clearest example. Beyond their effects on weight and blood sugar, they appear to reduce inflammation throughout the body and brain, often before any weight is lost.
That is one reason researchers are increasingly interested in what these medications mean for healthspan, the years we live with our minds, our bodies and our awareness intact.
What does preventive medicine look like in practice?
One speaker put it plainly. Traditional healthcare is reactive; we wait until someone is sick. The alternative is to build care around keeping people healthy in the first place, which means looking for risk while it is still quiet and still movable rather than waiting for it to announce itself.
That is the direction we are heading. We are thinking carefully about how to bring more of this science into the work we do, with sharper attention to the pillars that matter most.
And we are committed to bringing it to you while holding on to what has always been at the center of this practice. The coaching, the validation, the time, and the trust that have helped so many people already.
